Predict your next investment

Venture Capital
adventventures.com

See what CB Insights has to offer

Investments

79

Portfolio Exits

29

Funds

1

About Advent Venture Partners

Founded in 1981, Advent Venture Partners is a venture capital firm in Europe. Advent has over Euro 500m of fund commitments under management, their focus is on venture and growth investment in two sectors: Life Sciences and Technology.

Advent Venture Partners Headquarter Location

158-160 North Gower Street

London, England, NW1 2ND,

United Kingdom

+44 (0)20 7932 2100

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Advent Venture Partners News

Acutus Medical Raises $170M in Financing

Jun 20, 2019

This included a $100m Series D equity financing and a $70m credit facility. The Series D equity financing included new investors 8VC, Opaleye Management, Pura Vida Investments, and existing investors OrbiMed, Deerfield Management Company, Advent Venture Partners, Xeraya Capital and GE Ventures. The credit facility was provided by OrbiMed Credit and Royalties Fund and Deerfield Management. The company intends to use the funds to accelerate commercialization and facilitate global business development activities. Proceeds will allow Acutus to increase market availability of its FDA and CE marked AcQMap™ products as well as a suite of FDA-cleared, EP-designed vascular access products – AcQCross QX, AcQGuide Flex™ and AcQGuide Mini™. Founded in 2011 by Vince Burgess, CEO, Acutus provides next-generation electrophysiology technology solutions that can enable personalized and adaptive approaches to therapy. Its AcQMap is cardiac imaging and mapping system that incorporates precision ultrasound atrial anatomy reconstruction and reproducible, high-definition non-contact charge density mapping. The system also provides workhorse contact mapping capabilities, available in Europe. AcQMap’s increased clarity of arrhythmia pattern mapping aids in the development of patient specific ablation strategies. FinSMEs 20/06/2019

Advent Venture Partners Investments

79 Investments

Advent Venture Partners has made 79 investments. Their latest investment was in Paxmedica as part of their Debt on November 11, 2020.

CBI Logo

Advent Venture Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/6/2020

Debt

Paxmedica

$3M

Yes

1

6/20/2019

Series D

Acutus Medical

$100M

Yes

3

5/4/2016

Series F

Farfetch

$110M

No

13

3/3/2015

Series D

Subscribe to see more

$99M

Subscribe to see more

10

12/31/2014

Seed VC

Subscribe to see more

$99M

Subscribe to see more

0

Date

11/6/2020

6/20/2019

5/4/2016

3/3/2015

12/31/2014

Round

Debt

Series D

Series F

Series D

Seed VC

Company

Paxmedica

Acutus Medical

Farfetch

Subscribe to see more

Subscribe to see more

Amount

$3M

$100M

$110M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

3

13

10

0

Advent Venture Partners Portfolio Exits

29 Portfolio Exits

Advent Venture Partners has 29 portfolio exits. Their latest portfolio exit was Acutus Medical on August 06, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/6/2020

IPO

$99M

Public

5

4/16/2019

IPO

$99M

Public

5

9/21/2018

IPO

$99M

Public

6

4/28/2017

IPO

Subscribe to see more

$99M

Subscribe to see more

10

2/15/2017

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/6/2020

4/16/2019

9/21/2018

4/28/2017

2/15/2017

Exit

IPO

IPO

IPO

IPO

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Public

Subscribe to see more

Subscribe to see more

Sources

5

5

6

10

10

Advent Venture Partners Acquisitions

3 Acquisitions

Advent Venture Partners acquired 3 companies. Their latest acquisition was Nexi on June 19, 2015.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

6/19/2015

$99M

Acq - Fin

2

6/3/2009

Debt

Subscribe to see more

$99M

Subscribe to see more

10

1/1/2002

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/19/2015

6/3/2009

1/1/2002

Investment Stage

Debt

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Total Funding

Note

Acq - Fin

Subscribe to see more

Subscribe to see more

Sources

2

10

10

Advent Venture Partners Fund History

1 Fund History

Advent Venture Partners has 1 fund, including Advent Life Sciences Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/10/2014

Advent Life Sciences Fund II

$146.3M

1

Closing Date

9/10/2014

Fund

Advent Life Sciences Fund II

Fund Type

Status

Amount

$146.3M

Sources

1

Advent Venture Partners Team

3 Team Members

Advent Venture Partners has 3 team members, including former General Partner, Peter Baines.

Name

Work History

Title

Status

Peter Baines

Advent Life Sciences, Permira, PwC, and Picker

General Partner

Former

Michael Chalfen

General Partner

Former

Frédéric Court

General Partner

Former

Name

Peter Baines

Michael Chalfen

Frédéric Court

Work History

Advent Life Sciences, Permira, PwC, and Picker

Title

General Partner

General Partner

General Partner

Status

Former

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.